Pharmorubicin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pharmorubicin, covering 2016-02-15 to 2025-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors [Phase 2]